Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data
晚期肾细胞癌患者接受舒尼替尼或帕唑帕尼作为一线靶向治疗期间的真实世界经济结果:一项基于医疗保险索赔数据的回顾性分析
期刊:
影响因子:
doi:10.18553/jmcp.2018.24.6.525
Vogelzang, Nicholas J; Pal, Sumanta K; Ghate, Sameer R; Li, Nanxin; Swallow, Elyse; Peeples, Miranda; Zichlin, Miriam L; Meiselbach, Mark K; Perez, Jose Ricardo; Agarwal, Neeraj